The Justa & Lars Honors Bob Brinker Investment Club Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Justa & Lars Honors Bob Brinker Investment Club

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: marc ultra who wrote (12132)	2/26/2000 2:26:00 PM
From: marc ultra	Read Replies (3) of 15132

OT:Cancer and ENMD article. The Chicago Tribune will have a 3 day series on new cancer treatments starting on Sunday. On Tuesday the focus is suppose to be on a patient who is receiving Endostatin. Don't know what will be said but the reporter is one who has been closely following and one who has given favorable treatment to angiogenesis inhibitor therapy in the past. Might be a stock moving event as Endostatin trial results to date has been under a shroud of secrecy. As usual this is not a recommendation to buy at these prices. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next